Encyclosphere.org ENCYCLOREADER
  supported by EncyclosphereKSF

Ganciclovir description

From Wikidoc - Reading time: 1 min

Ganciclovir
VITRASERT® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Clinical Studies
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Description[edit | edit source]

The Vitrasert Implant contains the antiviral drug ganciclovir. Each Vitrasert Implant contains a minimum of 4.5 mg ganciclovir.

Each Vitrasert Implant contains a ganciclovir tablet which contains the inactive ingredient, magnesium stearate (0.25%). Each tablet is coated with polyvinyl alcohol and ethylene vinyl acetate polymers.

The chemical name of ganciclovir is 9-[[2-hydroxy -1- (hydroxymethyl)ethoxy] methyl]guanine, and has the following structure:

[1]

References[edit | edit source]

  1. "http://www.drugbank.ca/system/fda_labels/DB01004.pdf?1265922812" (PDF). External link in |title= (help)

Adapted from the FDA Package Insert.


Licensed under CC BY-SA 3.0 | Source: https://www.wikidoc.org/index.php/Ganciclovir_description
2 views | Status: cached on December 11 2023 23:46:31
↧ Download this article as ZWI file
Encyclosphere.org EncycloReader is supported by the EncyclosphereKSF